The cost of cancer treatment has garnered more headline attention since the Food and Drug Administration approved Bristol-Myer Squibb Co.’s drugs Yervoy and Opdivo for the treatment of advanced melanoma in October 2015. The drugs work in combination to boost a patient’s immune system…and cost more than $250,000 per year. [August 2016, 783 word article]